(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.53% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 17.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,593.66%.
Avient's revenue in 2026 is $3,246,100,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $310,675,389,804, with the lowest AVNT revenue forecast at $294,010,809,508, and the highest AVNT revenue forecast at $324,318,370,376.
In 2027, AVNT is forecast to generate $320,838,952,512 in revenue, with the lowest revenue forecast at $302,068,408,772 and the highest revenue forecast at $339,517,932,624.